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Purpose: Growing evidence suggests that successful treatment of many inherited photoreceptor diseases will require
multi-protein therapies that not only correct the genetic defects linked to these diseases but also slow or halt the related
degenerative phenotypes. To be effective, it is likely that therapeutic protein expression will need to be targeted to specific
cell types. The purpose of this study was to develop dual-promoter lentiviral vectors that target expression of two proteins
to retinal cones and rods, rods only, or Müller cells.
Methods:  Dual-promoter  lentivectors  were  constructed  using  the  following  promoters:  Xenopus  opsin  promoter
(XOPS)1.3, murine opsin promoter (MOPS), interphotoreceptor retinoid binding protein promoter (IRBP156), rhodopsin
kinase (RK), neural retina leucine zipper (NRLL), vimentin (VIM), cluster differentiation (CD44), and glial fibrillary
acidic protein (GFAP). Vectors were packaged and injected into the neural tubes of chicken embryos. The activities of
the promoters alone, in duplicate, or when paired with a different promoter were analyzed in transduced, fully-developed
retinas, using direct fluorescent and immunofluorescent microscopy.
Results: IRBP156, NRLL, and RK were active in cones and rods while XOPS1.3 was active only in rods. Of the glial
promoters, only GFAP activity was restricted to Müller cells; both VIM and CD44 were active in Müller and neural cells.
Dual-promoter vectors carrying IRBP156 and RK or XOPS1.3 and MOPS, in the order listed, exhibited robust expression
of both reporter transgenes in cones and rods or rods only, respectively. Expression of the upstream transgene was much
lower than the downstream transgene in dual-promoter vectors constructed using two copies of either RK or IRBP156.
Analyses of the expression of a dual-promoter vector carrying CD44 and VIM in the order listed showed that the activity
of the VIM promoter was more restricted to glial cells when paired with the CD44 promoter, while the activity of the
CD44 promoter was inhibited to the extent that no CD44-driven reporter protein was detected in transduced cells.
Conclusions: We have identified two dual-promoter vectors, one that targets cones and rods and one that targets rods
alone. Both vectors reliably express the two proteins encoded by the transgenes they carry. When two well matched
promoters are not available, we found that it is possible to target expression of two proteins to single cells using dual-
promoter vectors carrying two copies of the same promoter. These vectors should be useful in studies of retina when co-
delivery of a reporter protein with an experimental protein is desired or when expression of two exogenous proteins in
targeted cells is required.
Treatment strategies for inherited photoreceptor disease
often involve delivery of normal copies of the diseased gene
to the affected photoreceptor cells. This unimodal gene-based
treatment approach has been shown to restore function to
nonfunctioning  photoreceptors  [1-3]  and  sight  to  blind
animals, but in many cases the benefits have been relatively
short lived, slowing but not preventing the natural course of
the disease [4]. An alternative strategy that merits further
investigation  is  to  identify  complementary  or  synergistic
therapies that, when combined with corrective gene therapies,
yield greater and more prolonged therapeutic or even curative
benefits. Neurotrophic and anti-apoptotic therapies fit nicely
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into multimodal photoreceptor treatment strategies since these
agents, when administered alone [5-10] or in combination
with corrective gene therapies [11-13], have been shown to
slow many retinal diseases. The full power of these therapies
is  likely  to  be  realized  only  when  these  combination
treatments are specifically targeted to the cells requiring them.
Lentiviral vectors have been the vector of choice in many
applications  requiring  expression  of  multiple  proteins  in
single cells. In most of these applications, the goal has been
to produce vectors that express comparable levels of all of the
proteins encoded by the vector transgene, a goal that remains
one  of  the  most  significant  hurdles  facing  developers  of
polycistronic vectors. Several approaches have been used to
obtain  multiple  proteins  from  a  single  vector  including
insertion of internal ribosome entry sites, or 2A “cleavage”
peptide  sequences  between  the  cistrons  [14,15],  and
construction  of  vectors  that  carry  multiple  independent
transcriptional units [16,17]. All of these approaches have
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916proven useful, but their successful implementation has often
required  extensive  paradigm-specific  optimization  of  the
vectors.
We  recently  completed  a  study  to  investigate  the
feasibility of using dual-promoter lentiviral vectors to achieve
targeted expression of two proteins from a single vector. In
that study we found that pairing the murine interphotoreceptor
retinoid  binding  protein  promoter  (IRBP1783)  and  the
chicken  guanylate  cyclase  activating  protein  1  promoter
(GCAP292) resulted in specific expression of both cistrons in
cone cells. Pairing IRBP1783 with the murine opsin promoter
(MOPS) resulted in expression of the IRBP1783 cistron in
cone cells and expression of the MOPS cistron in rod cells
[18]. The goal of the current study was to determine if we
could  develop  dual-promoter  lentiviral  vectors  that
specifically target cones and rods, rods only, or Müller cells.
Several  vectors  were  developed  using  four  additional
photoreceptor promoters and three putative glial promoters in
chicken retina. The promoters exhibiting the desired activity
profiles were then paired and used to construct several dual-
promoter vectors whose activity profiles were also examined
in vivo. Our efforts resulted in construction of two vectors,
one that specifically targets cones and rods and one that targets
rods  only,  both  of  which  should  be  useful  in  situations
requiring expression of two exogenous proteins in these cells.
METHODS
Animals:  All  animal  protocols  were  approved  by  the
University  of  Florida  Institutional  Animal  Care  and  Use
Committee and adhered to the policies outlined in the Guide
for the Care and Use of Laboratory Animals [19]. All eggs
used in this study were obtained from our wild-type Rhode
Island Red and our GUCY1*B breeding colonies that we
maintain  at  the  University  of  Florida.  The  GUCY1*B
chickens carry a null mutation in the guanylate cyclase–1 gene
[4,20].
Embryonic injections: All lentiviral vectors were injected into
embryonic day 2 (E2) chicken embryos (stage 9–11 [21]) as
previously described [18]. Briefly, approximately 345 nl of
virus was injected into the anterior neural tube. In instances
where two different viruses were co-injected, equal volumes
of  virus  were  mixed  together  and  were  then  injected.
Following  injection,  eggs  were  sealed  with  Parafilm  M
(Pechinery Plastic Packaging, Chicago, IL) and incubated to
E20. For these experiments 10–15 eggs were injected with
each  virus  preparation.  Approximately  20%–50%  of  the
injected embryos survived to E20, and of those the retinas of
approximately 50%–80% exhibited sufficient levels of viral
transduction  to  permit  analyses  of  the  expression
characteristics  of  the  virus.  A  minimum  of  two  treated
embryos (four retinas) were analyzed for each vector at E20,
an age when the chicken retina is fully-developed.
Construction of lentiviral vectors: All lentiviral transducing
vectors were designed using SimVector 4.01 (Premier Biosoft
International; Palo Alto, CA). Fragments used in constructing
vectors  were  obtained  using  either  standard  restriction
enzyme digests or were amplified from existing vectors using
primers  shown  in  Table  1  and  Pfu  DNA  polymerase
(Stratagene; La Jolla, CA). Vector backbones used in non-
directional  ligations  were  dephosphorylated  using  shrimp
alkaline  phosphatase  (Promega;  Madison,  WI)  before
ligation. Ligations were performed using a Quick Ligation kit
(New England BioLabs; Ipswich, MA). The desired vectors
were  identified  by  restriction  analyses  of  plasmid  DNA
isolated  from  One  Shot  TOP10  chemically  competent
Escherichia coli cells (Invitrogen, Carlsbad, CA) that had
been transformed with the ligation mixtures. The maps and
sequences of all of the vectors described in this study are
available online through everyVECTOR. Shared access to this
information can be obtained by contacting the corresponding
author.
Vector elements: The pFIN lentiviral vector backbone used in
this  study  that  includes  a  woodchuck  hepatitis  post-
transcriptional regulatory element (WPRE), two copies of the
250 bp core region of chicken β-globin insulator (HS4), and
a central polypurine tract and central termination sequence
(cPPT/CTS) that creates a plus strand overlap of the vector
DNA (FLAP) during reverse transcription of the viral RNA,
has previously been described [18]. The following promoters
were used in our constructs: cluster differentiation (CD) 44,
elongation  factor-1α  (EF1α),  glial  fibrillary  acidic  protein
(GFAP), guanylate cyclase activating protein-1 (GCAP) 292,
interphotoreceptor retinoid binding protein promoter (IRBP)
156 and 1783, murine opsin promoter (MOPS), neural retina
leucine  zipper  (NRLL),  rhodopsin  kinase  (RK),  vimentin
(VIM) and the Xenopus opsin promoter (XOPS)1.3. We used
the  fluorescent  reporter  proteins  tdTomato  (tdTOM),
mCherry (CHER), and green fluorescent protein (GFP) to
monitor the activities of the promoters in chicken retina.
Photoreceptor promoter vectors:
       pFIN-IRBP1783-tdTOM:     This    vector    was    con-
structed as previously described [18].
pFIN-IRBP156-tdTOM: tdTOM was excised from pFIN-
IRBP1783-tdTOM using PmeI and SalI sites and was ligated
into the pFIN backbone [18]. pFIN-tdTOM was then cut with
NotI and NheI and the mouse IRBP156 (350 bp) promoter,
which  was  amplified  using  sense  and  antisense  primers
containing  NotI  and  NheI  sites,  respectively,  and  the
IRBP1783 promoter as a template, was ligated into pFIN-
tdTOM to create pFIN-IRBP156-tdTOM.
pFIN-RK-GFP-WPRE:  The  human  rhodopsin  kinase
(RK) promoter extending from −112 to +180 (292 bp) [22]
was amplified from p150E1E2EG using sense and antisense
primers containing BamHI and KpnI sites, respectively. The
RK promoter was ligated into pFIN that had been digested
with BamHI and KpnI. The resulting pFIN-RK vector was cut
with  KpnI.  GFP-WPRE  (GW)  was  removed  from
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University of California, Berkeley, CA) using KpnI and was
ligated into pFIN-RK to create pFIN-RK-GFP-WPRE.
pFIN-XOPS1.3-tdTOM:  pFIN-EF1α-tdTOM,  an
intermediate vector generated during construction of EF1α-
tdTOM-GCAP292-GFP  [18],  was  digested  with  NotI  and
NheI to remove the EF1α promoter. The XOPS1.3 promoter
(1370 bp) [23] was amplified from XOPS1.3p44/GFP using
sense and antisense primers containing NotI and NheI sites,
respectively, digested with NotI and NheI, and ligated into
pFIN-tdTOM to create pFIN-XOPS1.3-tdTOM.
pFIN-NRLL-tdTOM: pFIN-EF1α-tdTOM was digested
with NotI and NheI to remove EF1α. The mouse neural retina
leucine  zipper  (NRLL)  promoter  (2,591  bp)  [24]  was
amplified from pEGFP1-pNRLL (kindly provided by Anand
Swaroop, National Eye Institute, Bethesda, MD) using sense
and  antisense  primers  containing  NotI  and  NheI  sites,
respectively,  and  was  ligated  into  pFIN-tdTOM  to  create
pFIN-NRLL-tdTOM.
pFIN-GCAP292-GFP:  GCAP292-GFP  was  obtained
from pFIN-EF1α-tdTOM-GCAP292-GFP [18] using SalI and
was ligated into our pFIN transducing vector that had been
linearized with SalI.
Non-photoreceptor promoter vectors:
        pFIN-CD44-GFP-WPRE: pFmCD44.1GW [25] (kindly
provided  by  John  Flannery,  University  of  California,
Berkeley, CA) was digested with BamHI and KpnI to remove
the  murine  CD44  promoter  (BamHI  fragment)  and  GFP-
WPRE (KpnI fragment). Our pFIN transducing vector was
digested with BamHI, and CD44 was ligated into the vector.
TABLE 1. PCR PRIMERS FOR LENTIVIRUS VECTOR CONSTRUCTS
Vector insert Primer name Sequence
RK    
  S-BamHI TTAGGATCCGGGCCCCAGAAGCCT
  S-EcoRV TTAGATATCGGGCCCCAGAAGCCT
  AS- KpnI ATTGGTACCGCCCTTGGCCTGTGG
  AS-PmeI ATTGTTTAAACGCCCTTGGCCTGTGG
XOPS    
  S-NheI ATTGCGGCCGCAGATCTTTATACATTGCT
  AS-NheI AATGCTAGCCTCGAGATCCCTAGAAGC
NRLL    
   S-NotI TTGCGGCCGCGCGCTACCGGACTCA
  AS-NheI GCGCTAGCGGCGACCGGTGGAT
EFIα    
  S-NotI ATTGCGGCCGCTTTGGAGCTAA
  AS-NotI TTAGCGGCCGCCACGACACCTGAAAT
WPRE    
  S-SpeI ATAACTAGTATAATCAACCTCTGGATT
  S-MluI ATAACGCGTATAATCAACCTCTGGATT
  S-KpnI GGTGGTACCATAATCAACCTCTGGATT
  AS-SpeI ATAACTAGTGGTCGACGGTATCGATGC
  AS-MluI ATAACGCGTGGTCGACGGTATCGATGC
  AS-KpnI ATAGGTACCGGTCGACGGTATCGATGC
mCherry    
  S-NheI AAAGCTAGCAAGGATCCCGCCACC
  AS-NheI,MluI AAAGCTAGCACGCGTCGTACGTCGGGCTTTGT
GFP    
  S-NheI GCAGCTAGCCGCCACCATGAGCAA
  AS-NheI, MluI AATGCTAGCACGCGTCGTACGAGAGGCCTCAG
  S-XhoI CCTCTCGAGCGCCACCATGAGCAA
  AS-XhoI AATCTCGAGAGAGGCCTCAGTCAG
IRBPI56    
  S-NheI TTGCGGCCGCGCGCTACCGGACTCA
  AS-NotI GCGCTAGCGGCGACCGGTGGAT
RK-GFP    
  S-SpeI ATACTAGTGGGCCCCAGAAGCCT
  AS-SpeI, MluI  
  S-XhoI ATCTCGAGGGGCCCCAGAAGCCT
  AS-XhoI ATCTCGAGGATATCTTACTTGTACAGCTCGTCC
tdTomato    
  S-PmeI AATGATGTTTAAACCTGTACGACGATGACGATAAG
  AS-SalI TTACATGTCGACTCCTTTCGGGCTTTGTTA
Vimentin    
  S-MluI GGCACGCGTCTGTTTTACCCACCATCTCAGTTCTAATATT
  AS-MluI GGCACGCGTGGTACCCGGGGATCCACTAGTTCTAGAAAT
Molecular Vision 2010; 16:916-934 <http://www.molvis.org/molvis/v16/a102> © 2010 Molecular Vision
918The resulting pFIN-CD44 vector was then digested with KpnI,
and GFP-WPRE was ligated into it to create pFIN-CD44-
GFP-WPRE.
pFmVIMGW and pFmGFAPGW: The pFmVIMGW and
pFmGFAPGW lentiviral vectors [25] containing the murine
vimentin (VIM) and GFAP promoters driving enhanced GFP
(G), respectively, followed by a WPRE element (W), were
kindly provided by John Flannery (University of California,
Berkeley, CA).
pFIN-EF1α-CHER-WPRE:  EF1α  (1,458  bp)  was
amplified from pFIN-EF1α-tdTOM using sense and antisense
primers  containing  NotI  sites  and  was  ligated  into  pFIN-
WPRE that was linearized with NotI. mCherry (CHER: 790
bp) was amplified from pRSET-B-mCherry (kindly provided
by Roger Tsien, University of California, San Diego) using
sense and antisense primers containing NheI and NheI and
MluI, respectively. CHER was then digested with NheI and
ligated into pFIN-EF1α-WPRE that had been linearized with
NheI.
pFIN-EF1α-GFP-WPRE: pFIN-EF1α-GFP was digested
with NheI to remove GFP. A unique MluI site was added to
the vector by re-amplifying GFP (735 bp) using sense and
antisense primers containing NheI, and NheI and MluI sites,
respectively,  digesting  the  amplified  GFP  with  NheI,  and
ligating  it  back  into  pFIN-EF1α.  WPRE  (625  bp)  was
amplified  from  pFIN-RK-GFP-WPRE  using  sense  and
antisense primers containing MluI sites. Finally, pFIN-EF1α-
GFP and the WPRE were digested with MluI and ligated
together to create pFIN-EF1α-GFP-WPRE.
Dual  promoter  vectors:  All  dual  promoter  vectors  were
constructed by inserting two transgenes, each consisting of a
promoter plus a reporter, into the multiple cloning site of our
pFIN  transducing  vector  backbone.  The  transgenes  were
arranged head-to-tail so that transcription of both transgenes
proceeded in the same direction. The transgenes shared the
same polyadenylation site, which was located in the dl.R
region of the 3′ long-terminal repeat [18].
pFIN-RK-GFP-IRBP156-CHER-WPRE:  CHER  was
removed from pRSET-B-mCherry using BamHI and EcoRI
and  was  ligated  into  our  pFIN  transducing  vector.  The
resulting  pFIN-CHER  vector  was  digested  with  NotI  and
NheI. IRBP156 (350 bp) was amplified from pFIN-IRBP1783
using a sense and antisense primers containing NotI and NheI
sites,  respectively,  and  was  ligated  into  the  pFIN-CHER
vector to create pFIN-IRBP156-CHER. RK-GFP (1,040 bp)
was amplified from pFIN-RK-GFP-WPRE using sense and
antisense  primers  containing  XhoI  sites.  pFIN-IRBP156-
CHER and RK-GFP were digested with XhoI and were ligated
together.  WPRE  (613  bp)  was  amplified  from
pFmCD44.1GW using sense and antisense primers containing
SpeI sites. pFIN-RK-GFP-IRBP156-CHER and WPRE were
digested with SpeI and ligated together to create the final
vector.
pFIN-IRBP156-CHER-RK-GFP-WPRE:  RK-GFP
(1,040 bp) was amplified from pFIN-RK-GFP-WPRE using
sense and antisense primers containing SpeI and SpeI and
MluI sites, respectively. RK-GFP and pFIN-IRBP156-CHER,
an intermediate vector in the construction of pFIN-RK-GFP-
IRBP156-CHER-WPRE, were digested with SpeI and ligated
together to create pFIN-IRBP156-CHER-RK-GFP. Finally,
WPRE flanked with MluI sites (described above) was ligated
into pFIN-IRBP156-CHER-RK-GFP that had been digested
with MluI.
pFIN-RK-GFP-RK-CHER-WPRE:  pFIN-CHER  was
digested with XhoI. RK-GFP was removed from pCR2.1-RK-
GFP using XhoI and ligated into pFIN-CHER, creating pFIN-
RK-GFP-CHER. A second copy of the RK (312 bp) promoter
was amplified from pFIN-RK-GFP-WPRE using sense and
antisense  primers  containing  EcoRV  and  PmeI  sites,
respectively.  pFIN-RK-GFP-CHER  and  the  RK  promoter
were digested with EcoRV and PmeI and were ligated together
to  create  pFIN-RK-GFP-RK-CHER.  Finally,  WPRE  was
amplified with primers containing SpeI sites and was ligated
pFIN-RK-GFP-RK-CHER that had been linearized with SpeI.
pFIN-IRBP156-CHER-IRBP156-GFP-WPRE:  pFIN-
IRBP156-CHER  was  digested  with  SpeI.  IRBP156-GFP
(1,119 bp) was amplified from pFIN-IRBP1783-GFP using a
sense  primer  containing  SpeI  and  EcoRV  sites  and  an
antisense primer containing SpeI and MluI sites.The amplified
IRBP156-GFP was digested with SpeI and ligated into pFIN-
IRBP156-CHER to create pFIN-IRBP156-CHER-IRBP156-
GFP. Finally, WPRE, amplified from pFIN-RK-GFP-WPRE
using sense and antisense primers containing MluI sites, and
pFIN-IRBP156-CHER-IRBP156-GFP  were  digested  with
MluI and ligated together to create the final vector.
pFIN-XOPS-tdTOM-MOPS-GFP: pFIN-XOPS-tdTOM
was linearized with SalI. MOPS-GFP was extracted from
pFIN-MOPS-GFP [18] using SalI sites and was ligated into
pFIN-XOPS-tdTOM  to  form  pFIN-XOPS-tdTOM-MOPS-
GFP.
pFIN-MOPS-GFP-XOPS-tdTOM-WPRE: pFIN-XOPS-
tdTOM was digested with KpnI. WPRE was amplified from
pFIN-WPRE  (628  bp)  using  sense  and  antisense  primers
containing  KpnI  sites  and  was  ligated  into  pFIN-XOPS-
tdTOM.  MOPS  was  excised  from  pFIN-MOPS-GFP  [18]
using NotI and ligated into pFIN-XOPS-tdTOM that had been
linearized with NotI to create pFIN-MOPS-XOPS-tdTOM-
WPRE. Finally, GFP (763 bp) was amplified from pFIN-
EF1α-GFP using sense and antisense primers containing XhoI
sites and ligated into pFIN-MOPS-XOPS-tdTOM-WPRE that
had been linearized using XhoI to create pFIN-MOPS-GFP-
XOPS-tdTOM-WPRE.
pFIN-CD44-CHER-VIM-GFP-WPRE:  pFIN-CD44-
GFP-WPRE was linearized using AgeI. CHER (797 bp) was
amplified  from  pFIN-IRBP1783-CHER  using  sense  and
antisense primers containing AgeI and AgeI, and MluI sites,
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919respectively,  and  ligated  into  pFIN-CD44-GFP-WPRE  to
create pFIN-CD44-CHER-GFP-WPRE. The VIM promoter
(3,195 bp) was amplified from pFmVIMGW using sense and
antisense primers containing MluI sites and ligated into pFIN-
CD44-CHER-GFP-WPRE that had been linearized with MluI
to form pFIN-CD44-CHER-VIM-GFP-WPRE.
HS4 vectors:
       pFIN-RK-GFP-HS4(2×250)F-IRBP156-CHER-WPRE:
pFIN-RK-GFP-IRBP156-CHER was digested with EcoRV.
pNI-CD  (kindly  provided  by  Gary  Felsenfeld,  National
Institutes of Health, Bethesda, MD) was cut with KpnI to
obtain the 500 bp HS4(2×250) insulator. HS4(2×250) was
treated with T4 DNA polymerase and ligated into pFIN-RK-
GFP-IRBP156-CHER in the forward (F) orientation. WPRE
(613 bp) was amplified from pFmCD44.1GW using sense and
antisense primers containing SpeI sites and was ligated into
the  pFIN-RK-GFP-HS4(2×250)F-IRBP156-CHER  vector
that had been linearized using SpeI.
pFIN-RK-GFP-HS4(1.2)F-IRBP156-CHER-WPRE:
pNI-CD was cut with XbaI to obtain the 1.2-kb HS4 fragment.
The construction of this vector was the same as that used for
pFIN-RK-GFP-HS4(2×250)F-IRBP156-CHER  except  that
the HS4 1.2-kb fragment was ligated into pFIN-RK-GFP-
IRBP156-CHER in the forward orientation. WPRE (613 bp)
was  amplified  from  pFmCD44.1GW  using  sense  and
antisense primers containing SpeI sites and was ligated into
the  pFIN-RK-GFP-HS4(1.2)F-IRBP156-CHER  vector  that
had been linearized using SpeI.
Packaging and titering lentiviruses: The lentiviral vectors
described above were packaged into vesicular stomatitis virus
G (VSV-G) glycoprotein pseudotyped lentivirus, using a three
plasmid packaging system as previously described [18,26].
The titer of each lentivirus (viral genomes/µl) was determined
using a Lenti-X qRT–PCR titration kit (Clontech, Mountain
View, CA). The average titer of the viruses used in this study
was  7.45×1012  genomes/ml  ranging  from  1.85×1010  to
5.6×1013.
Retinal  whole-mounts  and  immunohistochemistry:  Retinal
whole mounts were prepared as previously described [18].
The GFP reporter protein was detected by examining the
whole  mounts  with  a  narrow-band  GFP  filter  set  41020
(Chroma Technology Corp, Bellows Falls, VT); CHER and
tdTOM  reporter  proteins  were  detected  using  a  Chroma
custom filter set that consisted of an exciter ET572/35, an
emitter ET632/60, and a beamsplitter (Chroma Technology
Corp,  Bellows  Falls,  VT).  The  expression  patterns  of  the
reporter  proteins  in  the  retinal  whole  mounts  were
documented using a Zeiss AxioCam MRm digital camera
(Carl Zeiss Microimaging, Inc.,Thornwood, NY). In selecting
the representative images shown in the figures, our goal was
to  document  all  of  the  cell  types  and  the  variability  in
expression  levels  of  the  reporter  proteins  observed  in
transduced cell populations. Co-expression of the reporter
proteins was analyzed using the co-localization module of the
Zeiss AxioVision Image analysis suite. The results of these
analyses were plotted using GraphPad Prism 5.02 (GraphPad
Software, Inc., La Jolla, CA).
For immunohistochemistry, the retinas were equilibrated
in 30% sucrose in phosphate buffered saline (137 mM NaCl,
2.7 mM KCl, 100 mM Na2HPO4, 2.0 mM KH2PO4) overnight,
cryosectioned  at  10  µm,  and  either  stained  with  4’,6-
diamidino-2-phenylindole (DAPI) alone or in combination
with a rod transducin polyclonal antibody (1:1,000; G-t1:
K20; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or a
mouse  monoclonal  antibody  against  chicken  carbonic
anhydrase II (CAII; 1:500: kindly provided by Paul Linser,
University  of  Florida,  Gainesville,  FL).  The  primary
antibodies were localized using either Alexa Fluor 488 or 594
secondary antibodies (Invitrogen). Zeiss filter set 02 was used
to visualize DAPI-stained cell nuclei. In experiments in which
virus expression was examined in brain, 10 µm sagittal brain
sections  were  stained  with  a  chicken  anti-GFP  antibody
(1:1,000;  ab13970;  Abcam,  Cambridge,  MA)  to  enhance
visualization of the GFP expressing cells and DAPI.
RESULTS
To develop dual-promoter vectors that specifically target both
cones and rods or that target rods only, we first needed to
identify  promoters  that  exhibited  these  expression
characteristics in vivo. To accomplish this, we constructed
four lentiviral vectors, each carrying a fluorescent reporter
protein whose expression was driven by IRBP156, XOPS,
NRLL, or RK (Figure 1). The first promoter examined was
mouse IRBP156, a truncated version of IRBP1783 whose
activity has been shown to be restricted to photoreceptors
[27,28], which we found to exhibit cone-specific activity in
chicken  retina  [18].  In  retinas  transduced  with  pFIN-
IRBP156-tdTOM  lentivirus,  tdTOM  was  detected  in  the
photoreceptor cells and occasionally in groups of cells in the
inner  nuclear  layer  (Figure  1A).  Sections  of  these  retinas
counterstained with an antibody against rod transducin alpha
revealed that unlike IRBP1783, IRBP156 was active in both
rod  and  cone  cells  (Figure  1B).  The  second  promoter
examined  was  the  Xenopus  opsin  promoter,  XOPS,  a
promoter  that  exhibits  rod-specific  activity  in  frog  retina
[23].  In  retinas  transduced  with  pFIN-XOPS1.3-tdTOM,
tdTOM expression was restricted to rod cells, as evidenced by
tdTOM  and  rod  transducin  alpha  co-localization  (Figure
1C,D). This expression pattern was identical to that which we
previously observed for the mouse opsin promoter MOPS
[18]. The third promoter examined was mouse NRLL, the
activity of which is restricted to rods in mouse retina [24]. In
fully differentiated chicken retinas transduced with pFIN-
NRLL-tdTOM, expression of tdTOM was restricted to the
photoreceptor layer but was not limited to rod cells. Unlike its
activity profile in mouse retina, NRLL exhibited activity in
both cones and rods in chicken retina (Figure 1E,F). The
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920expression pattern of the mouse NRLL promoter in chicken
cones and rods was unexpected. Searches performed by our
laboratory and others indicate that there are no well conserved
homologs of NRL in the chicken genome [29,30]. However,
NRL, which is a member of the Maf-family of transcription
factors, does exhibit extended homology with the chicken v-
maf musculoaponeurotic fibrosarcoma oncogene homolog K
(MAFK) that encodes v-maf [31]. Thus, the activity of the
mouse NRLL promoter in chicken cones and rods may reflect
differences in the transactivation of this promoter in birds and
mammals. Finally, the fourth promoter examined was human
RK, a promoter that is active in both cones and rods in mouse
and rat retinas [22,32]. In chicken retinas transduced with
pFIN-RK-GFP-WPRE,  GFP  expression  was  detected
primarily  in  cones  and  rods  (Figure  1G,H)  and  was
occasionally  observed  in  scattered  cells  within  the  inner
nuclear layer. In sum, of the four photoreceptor promoters
examined in this series of experiments, IRBP156, NRLL, and
RK exhibited activity in both cones and rods while XOPS
activity was restricted to rods (see Table 2 for summary).
In addition to photoreceptor targeted vectors, we also
wanted  to  develop  dual-promoter  vectors  that  specifically
target  Müller  cells.  As  a  first  step  toward  this  goal,  we
analyzed the expression characteristics of the murine CD44,
VIM, and GFAP promoters in chicken retina (Figure 2). All
three  of  these  promoters  have  been  reported  to  drive
expression of lentiviral transgenes in Müller cells in rat retina
[25]. To examine the expression characteristics of CD44, we
removed the promoter from pFmCD44.1GW [25] and inserted
it into our lentiviral backbone to create pFIN-CD44-GFP-
WPRE. In retinas transduced with lentivirus prepared using
this vector, GFP expression was detected in numerous retinal
cell types, including photoreceptors (Figure 2C), horizontal
cells (Figure 2D), amacrine cells (Figure 2E), Müller cells
(Figure 2F-H) and ganglion cells (Figure 2I). The cellular
specificities of the VIM and GFAP promoters in chicken
retina  were  determined  by  examining  GFP  expression  in
retinas  transduced  with  lentiviruses  prepared  using
pFmVIMGW  or  pFmGFAPGW  lentivectors  [25],
respectively.  VIM-driven  GFP  expression  in  retinas
transduced  with  pFMVIMGW  was  primarily  detected  in
horizontal cells (arrows; Figure 2J-M) and in Müller cells
(asterisks;  Figure  2L,M,O).  GFP  was  also  detected  in
photoreceptors (Figure 2N, arrow) and in cells in the inner
nuclear layer, which were identified as bipolar cells (Figure
2N, open arrowhead) and amacrine cells (Figure 2N, asterisk),
based on the position of their cell bodies within the inner
nuclear layer [33]. In our initial experiment to examine the
cellular  specificity  of  the  GFAP  promoter,  we  found  that
levels of expression of the GFAP-GFP transgene in the retinas
of  E20  wild-type  embryos  that  had  been  treated  with
pFmGFAPGW  lentivirus  was  very  low.  This  result  is
consistent with our previous study of GFAP expression in
chicken retina in which we found that the activity of the GFAP
promoter is low in normal retina and increases in the presence
of  injury  or  disease  [34].  To  better  assess  the  expression
characteristics of this promoter in chicken retina, we treated
E2  GUCY1*B  embryos  with  the  pFmGFAPGW  virus,
hatched the chickens, and examined the retinas of the animals
at  5  weeks,  a  time  when  retinal  degeneration  due  to  the
absence  of  guanylate  cyclase-1  is  well  underway  [35].
Examination of the retinas of these animals revealed that GFP
expression was restricted to Müller cells (Figure 2R-V). The
results of these analyses, summarized in Table 2, show that
the GFAP promoter exhibits the highest specificity for Müller
cells in chicken retina.
We have recently shown that it is possible to deliver
multi-protein  therapies  to  retina  using  dual-promoter
lentivectors  carrying  multiple  transgenes  [18].  Another
approach that has been used to deliver multiple therapies to
retina has been to administer a mixture of two or more viruses
to the retina, each virus carrying a transgene whose expression
is  regulated  by  a  promoter  with  well  defined  expression
characteristics [11-13]. Before moving on to developing cell-
specific  dual-promoter  vectors  to  deliver  two  therapeutic
proteins to single cells, we wanted to determine if we could
achieve this goal using mixtures of lentiviruses, each encoding
a  specific  protein.  To  address  this  question,  we  injected
mixtures  of  two  lentiviruses  into  the  neural  tubes  of  E2
embryos  and  monitored  expression  of  the  reporter  genes
carried by the viruses in retina and brain.
In our first series of experiments, we paired lentiviruses
carrying transgenes encoding fluorescent reporter proteins,
the  expression  of  which  was  driven  by  two  different
photoreceptor promoters possessing similar cellular activity
profiles:  (1)  pFIN-GCAP292-GFP  and  pFIN-IRBP1783-
tdTOM,  (2)  pFIN-RK-GFP-WPRE  and  pFIN-IRBP1783-
tdTOM, and (3) pFIN-RK-GFP-WPRE and pFIN-IRBP156-
tdTOM.  We  previously  found  that  the  GCAP292  and
IRBP1783 promoters are active in cone cells [18] and in this
study we found that RK and IRBP156 are active in both rod
and cone cells (Figure 1A,B,G,H). Examination of retinal
whole mounts treated with these virus mixtures revealed that
both viruses effectively transduced the target tissues and that
the expression of the fluorescent reporter proteins encoded by
the transgenes carried by the viruses were easily detected in
retinal whole mounts (Figure 3A-O). Within infected areas,
GFP or tdTOM were observed in more than half of the cells,
with little evidence of co-expression, a pattern suggesting that
few cells had been infected by both viruses. The retinal areas
shown  in  Figure  3  were  selected  because  they  contained
transduced  cells  expressing  both  GFP  and  tdTOM.  The
percentages  of  the  infected  cells  expressing  both  reporter
proteins in these transduced areas were 33% (Figure 3D,E),
24% (Figure 3I,J), and 16% (Figure 3N,O). In addition to
pairing lentiviruses carrying promoters with similar cellular
activity  profiles,  we  also  paired  lentiviruses  carrying
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921Figure 1. Cellular activities of interphotoreceptor retinoid binding protein promoter (IRBP156), Xenopus opsin promoter (XOPS), neural retina
leucine zipper (NRLL), and rhodopsin kinase (RK) promoters in chicken retina. Lentiviral vectors were injected into the ventricles of chicken
embryos (embryonic day 2 –E2) in ovo. The viruses injected were as follows: A-B pFIN-IRBP156-tdTOM; C-D pFIN-XOPS-tdTOM; E-F
pFIN-NRLL-tdTOM; G-H pFIN-RK-GFP-WPRE. The retinas of the injected embryos were harvested on E19–20 and the cells expressing
the fluorescent reporter proteins were identified using native fluorescent and immunofluorescent microscopy. In selecting the representative
images shown in this and subsequent figures, our goal was to document all of the cell types and the variability in expression levels of the
reporter proteins observed in transduced cell populations. The sections shown in B, D, F, and H were immunostained with a rod transducin
polyclonal antibody that was visualized using either goat anti-rabbit Alexa Fluor 488 (B, D, F) or 594 (H) secondary antibody. Arrows indicate
inner retinal cells (A) or rod photoreceptors (B, H). All sections were counterstained with DAPI. All scale bars shown equal 50 µm.
Abbreviations: ONL represents outer nuclear layer; INL represents inner nuclear layer.
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922promoters  with  different  cellular  activity  profiles:  pFIN-
GCAP292-GFP  and  pFIN-XOPS-tdTOM.  GCAP292,  as
indicated above, is active in cones, while XOPS is specifically
expressed in rod cells (Figure 1C,D). Our expectation was that
very few, if any, cells would co-express GFP and tdTOM in
retinas infected with this virus mixture. Analyses of these
retinas showed that only 6% of the infected regions exhibited
co-localization  (Figure  3R,S),  a  result  consistent  with  the
expression profiles of these promoters.
In our second series of experiments, we asked if delivery
of a mixture of two viruses carrying reporter proteins driven
by identical ubiquitously expressed promoters would increase
the  number  of  co-infected  cells,  as  evidenced  by  co-
localization  of  the  two  reporter  proteins.  To  address  this
question, we injected a mixture of pFIN-EF1α-CHER-WPRE
and pFIN-EF1α-GFP-WPRE that encoded either CHER or
GFP driven by the ubiquitous EF1α promoter and examined
expression of the fluorescent proteins in retina and brain.
Examination  of  treated  retinal  whole  mounts  revealed  a
patchwork  of  expression  of  GFP  and  CHER  with  little
evidence of co-localization of these proteins (Figure 4A,B).
Sections of these retinas revealed that GFP and CHER were
distributed throughout all of the layers of the retina (Figure
4C,E-G). Most retinal sections showed little evidence of co-
localization of GFP and CHER (Figure 4C,D). Analyses of
the image in Figure 4C showed that approximately 10% of the
total area expressing reporter protein (34% of the image)
contained  cells  expressing  both  proteins  (Figure  4D).  In
regions containing co-transduced cells, these cells were often
clustered (Figure 4E-G), a distribution pattern consistent with
viral infection of retinal progenitor cells in E2 embryos that
would  lead  to  expression  of  the  viral  transgenes  in  their
daughter  cells.  Analyses  of  these  regions  showed  that
approximately  33%  of  the  total  area  expressing  reporter
protein (30% of the image) contained cells expressing both
proteins  (Figure  4H).  Because  the  virus  pair  used  in  this
experiment  carried  the  ubiquitously  expressed  EF1α
promoter, we were able to examine transgene expression in
the  brains  as  well  as  the  retinas  of  treated  embryos.  The
expression patterns of GFP and CHER in brain were similar
to those observed in retina. In highly organized brain regions,
such as the optic tectum (Figure 4I box), both reporter proteins
were detected, but among the columns of cells expressing
these proteins, very few cell groups (3% of transduced area)
were identified that co-expressed these proteins (Figure 4J-L).
In sum, the results of this series of experiments show that
mixtures of viruses can be used to deliver two transgenes to a
target tissue but that this approach is not practicable to achieve
high levels of co-expression of two transgenes in individual
cells.
Given the results of our mixed virus experiments, we
returned our focus to developing dual-promoter vectors that
specifically target cones and rods, rods only, or Müller cells
and  reliably  express  both  transgenes,  features  that  would
increase  the  experimental  and  potentially  the  therapeutic
usefulness of the vectors. To build the dual promoter vector
targeting cones and rods, we selected the IRBP156 (392 bp)
and RK (250 bp) promoters, both of which exhibit strong
activity in cone and rod cells (Figure 1) and are relatively
small in size. We constructed four different dual-promoter
reporter vectors using these promoters and examined their
expression  in  vivo:  (1)  pFIN-RK-GFP-IRBP156-CHER-
WPRE;  (2)  pFIN-IRBP156-CHER-RK-GFP-WPRE;  (3)
pFIN-RK-GFP-RK-CHER-WPRE;  (4)  pFIN-IRBP156-
CHER-IRBP156-GFP-WPRE  (Figure  5).  Vectors  1  and  2
were constructed to determine if the order of appearance of
the  IRBP156-  and  RK-driven  transgenes  influenced  their
expression  levels.  Vectors  3  and  4  were  constructed  to
determine  if  photoreceptor-specific  dual-promoter  vectors
carrying two copies of the same promoter can be efficiently
packaged into lentivirus and if so, if expression of the two
transgenes  in  vivo  is  comparable.  Comparisons  of  the
expression  characteristics  of  vector  1  -  pFIN-RK-GFP-
IRBP156-CHER-WPRE  (Figure  5A-E,F-J)  and  vector  2  -
pFIN-IRBP156-CHER-RK-GFP-WPRE (Figure 5K-O,P-T)
showed that expression of the IRBP156-CHER transgene was
higher than that of the RK-GFP transgene regardless of its
position in the vector (compare Figure 5B,G to Figure 5A,F
and Figure 5K,P to Figure 5L,Q) and was highest when it was
located in the upstream position (compare Figure 5K,P to
Figure 5B,G). The percent of transduced cells co-expressing
detectable levels of GFP and CHER was much greater in
retinas  transduced  with  pFIN-IRBP156-CHER-RK-GFP-
WPRE  (60%–80%;  Figure  5N-O,S-T)  than  in  retinas
TABLE 2. SUMMARY OF PROMOTER ACTIVITIES IN CHICKEN RETINA
  Cells exhibiting promoter activity
Promoters Ganglion cells Müller cells Inner nuclear layer Photoreceptors Rods Cones
IRBP156     x   x x
XOPS         x  
NRLL         x x
RK         x x
CD44 x x x x    
VIM   x x x    
GFAP   x        
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923Figure 2. Cellular activities of cluster differentiation (CD)44, vimentin (VIM), and glial fibrillary acidic protein (GFAP) promoters in chicken
retina. Lentiviral vectors were injected into the ventricles of chicken embryos (embryonic day 2–E2) in ovo. The retinas of the injected embryos
were  harvested  on  E19–20  and  the  cells  expressing  the  fluorescent  reporter  proteins  were  identified  using  native  fluorescent  and
immunofluorescent microscopy. The viruses injected were as follows: A-I pFIN-CD44-GFP-WPRE; J-Q pFM-VIM-GW; R-V pFM-GFAP-
GW. All sections were counterstained with DAPI, and all scale bars shown equal 50 µm. Abbreviations are as follows: ONL represents outer
nuclear layer; INL represents inner nuclear layer; IPL represents inner plexiform layer; GCL represents ganglion cell layer. CD44: A:
Photograph of whole mount of retina that had been treated with pFIN-CD44-GFP-WPRE. Clusters of GFP-positive photoreceptors (arrows)
were detected across the surface of the whole mount. B: This image was produced by re-photographing the boxed region shown in A using a
focal plane just below that used to obtain the image shown in A. Horizontal cells (asterisks) were the predominant GFP-positive cell type
observed in this focal plane. C-I These images represent sections of retinas showing the cell types (arrows) in which the CD44-GFP transgene
was active (C photoreceptors, D horizontal cells, E amacrine cells, F-H Müller cells, I ganglion cells). Section shown in F was counterstained
with an antibody against chicken carbonic anhydrase II (CAII), a marker for Müller cells (G). The merged image (H) shows that the GFP-
positive cells also expressed carbonic anhydrase II. VIM: J, K Photographs of a whole mount of a retina treated with pFM-VIM-GW and
viewed from the photoreceptor side of the whole mount. J Numerous GFP-positive horizontal cells were detected in the transduced retina
(arrow). K Enlargement of the region in image J (box) that contains GFP-positive horizontal cells (arrow). L This image was produced by re-
photographing the boxed region shown in K using a focal plane just below that shown in K. Müller cell bodies are the predominant cell type
observed in this image plane (asterisk). The horizontal cell indicated in J, K, and L by the arrow is the same cell. M,N Images of sections of
the retinal whole mount shown in J and K. GFP-positive horizontal (M, arrow), Müller (M, asterisk), and photoreceptor (N, ONL) cells were
detected in several sections. O-Q A section containing GFP-positive cells located in the INL (O, arrow) was counterstained with an antibody
against chicken carbonic anhydrase II (P). The merged image (Q) shows that the GFP-positive cells also expressed carbonic anhydrase II.
GFAP: R, S Images of a whole mount of a 5-week old GUCY1*B chicken retina that had been treated with pFM-GFAP-GW on E2 and
photographed from either the photoreceptor (R) or the vitread (S) side of the whole mount. The pattern of GFP localization observed in these
whole mounts suggested that the cells expressing the GFAP-GFP transgene were Müller cells. T-V Sections of the transduced retinas showed
that the cell bodies of the GFP-positive cells observed in R and S were located in the INL (T). Immunostaining of these sections with an
antibody against chicken carbonic anhydrase II (U) revealed that the GFP-positive cells also expressed carbonic anhydrase II (V).
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924transduced  with  pFIN-RK-GFP-IRBP156-CHER-WPRE
(<20%; Figure 5D-E,I-J). We next examined the performance
of  vectors  3  -  pFIN-RK-GFP-RK-CHER-WPRE  and  4  -
pFIN-IRBP156-CHER-IRBP156-GFP-WPRE.  The
estimated titers of each of the viruses generated using these
vectors (vector 3, 1.85×1010 vector genomes/ml and vector 4,
1.7×1012 vector genomes/ml) were comparable to the average
titer of all of the viruses that we generated for this study
(7.45×1012 genomes/ml), indicating that the presence of two
identical promoters in the lentivector did not interfere with
packaging of the virus. Examination of retinas transduced
with either of these vectors revealed that both of the transgenes
carried by these vectors were expressed in 10%–50% of the
infected  cells  (Figure  5X,CC,HH,MM).  In  general,
expression  of  the  downstream  gene  was  higher  in  cells
expressing both transgenes (Figure 5; compare Figure 5V,AA
to Figure 5U,Z and Figure 5FF,KK to Figure 5EE,JJ). In
approximately  35%–70%  of  the  infected  areas,  only  the
downstream  reporter  protein  was  detected  (Figure
5X,CC,HH,MM).  In  sum,  our  data  indicate  that  pFIN-
IRBP156-CHER-RK-GFP-WPRE is the most efficient vector
of the four tested in terms of its ability to consistently express
both of the transgenes carried by the vector. As a final test of
the utility of this vector, we examined the cellular specificity
of the expression of the integrated transgenes in sections of
infected retinas. Examination of sections of retinas transduced
with pFIN-IRBP156-CHER-RK-GFP-WPRE virus revealed
that the individual expression characteristics of these two
Figure 3. Expression of photoreceptor promoter-driven fluorescent proteins in retinas transduced with mixtures of two lentiviruses. Lentiviral
vectors carrying transgenes comprised of various photoreceptor promoters driving expression of GFP or tdTOM fluorescent proteins were
mixed in equal volumes and injected into the developing neural tubes of chicken embryos (embryonic day 2 –E2) in ovo. The injected virus
mixtures were as follows: A-E: pFIN-GCAP292-GFP (2.2×1010 vector genomes/µl) and pFIN-IRBP1783-tdTOM (1.6×1010 vector genomes/
µl); F-J: pFIN-RK-GFP-WPRE (1.2×1010 vector genomes/µl) and pFIN-IRBP1783-tdTOM (1.6×1010 vector genomes/µl); K-O: pFIN-RK-
GFP-WPRE (1.2×1010 vector genomes/µl) and pFIN-IRBP156-tdTOM (5.6×1010 vector genomes/µl); P-T: pFIN-GCAP292-GFP (2.2×1010
vector genomes/µl) and pFIN-XOPS-tdTOM (1.2×109 vector genomes/µl). We have previously shown that the GCAP292 and IRBP1783
promoters are active in cone cells [18]. RK and IRBP156 are active in both rod and cone cells and XOPS is only active in rod cells (Figure
1). For each image series, the transduced retina was photographed from the photoreceptor side of the whole mount using GFP (A, F, K, P)
and CHER (B, G, L, Q) filters. These images were then merged to identify cells expressing both reporter proteins (C, H, M, R). The merged
images were analyzed using the co-localization module of the Zeiss AxioVision Image Suite. The results of these analyses are expressed as
the percent of the transduced area in the image (pixels) containing co-localized GFP and tdTOM (yellow bar) or GFP (green bar) or tdTOM
(red bar) fluorescence alone (D, I, N, S). The images shown in E, J, O, and T were extracted from the merged images shown in C, H, M, and
R and show only those areas of the merged image in which GFP was co-localized with tdTOM. The scale bar shown in A is applicable to all
images and equals 50 µm.
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925promoters  (Figure  1)  were  retained  in  the  dual-promoter
vector configuration. Robust expression of both CHER and
GFP was observed in the photoreceptor cell layer (Figure 6).
In addition, a few scattered cells expressing these proteins
were also detected in the inner nuclear layer of these retinas
(arrow; Figure 6D). These results support use of this dual-
promoter vector to target expression of two proteins to cone
and rod cells and are summarized in Table 3.
Before  leaving  our  efforts  to  construct  dual-promoter
vectors targeting both cones and rods, we conducted a series
of experiments to determine if we could improve expression
of the upstream transgene RK-GFP in the pFIN-RK-GFP-
IRBP156-CHER vector (Figure 5A-E,F-J) by separating the
two transgenes carried by the vector with insulator elements,
a strategy that has been shown to improve expression levels
of two independently regulated transgenes in lentiviral vectors
[16,36]. Two vectors were constructed for this experiment by
inserting either the core 2×250 bp or the 1.2 kb chicken β-
globin HS4 insulator in the forward orientation between the
upstream  (RK-GFP)  and  downstream  (IRBP156-CHER)
Figure 4. Expression of elongation factor 1a (EF1a) promoter-driven fluorescent proteins in retina and brain transduced with a mixture of two
lentiviruses. Equal volumes of two lentiviral vectors, pFIN-EF1a-GFP-WPRE (2.4×1010 vector genomes/µl) and pFIN-EF1a-CHER-WPRE
(4.6×109 vector genomes/µl), were mixed and injected into the developing neural tubes of E2 chicken embryos in ovo. The retinas and brains
of the injected embryos were harvested on E19-E20 and the cells expressing GFP and CHER were identified using fluorescent microscopy.
A, B These retinal whole mounts, viewed from the photoreceptor side, show the distribution of retinal cells expressing GFP and/or CHER
fluorescent protein(s). The scale bars in A and B equal 2000 and 50 µm, respectively. C-D and E-H: Sections of whole mounts shown in A
and B show that the EF1a promoter is active in cells distributed throughout the neural retina. C: This retinal section, which contains very few
transduced cells expressing both GFP and CHER, was typical of most regions of the transduced retinas. D: The image shown in C was analyzed
using the co-localization module of the Zeiss AxioVision Image Suite. The results of these analyses are expressed as the percent of the
transduced area in the image (pixels) containing co-localized GFP and CHER (yellow bar) or GFP (green bar) or CHER (red bar) fluorescence
alone. E-G: Image of retinal section showing green (E), red (F) and merged (G) channels that contain several cells expressing both GFP and
CHER. H: The image shown in E was analyzed using the co-localization module of the Zeiss AxioVision Image Suite. The results of this
analysis are expressed as the percent of the transduced area in the image (pixels) containing co-localized GFP and CHER (yellow bar) or GFP
(green bar) or CHER (red bar) fluorescence alone. The scale bars in C and D equal 50 µm. I: Thionin stained sagittal section of E20 chicken
brain. Scale bar equals 1000 µm. J-L: Fluorescent images of GFP and CHER expression in optic tectum (the region shown in F-F’’ corresponds
to the boxed region in I). The brain sections were stained with a chicken anti-GFP antibody to enhance visualization of the GFP expressing
cells. Tectal layers are numbered according to Cajal [43]. Scale bar in J equals 100 µm. Retinal and brain sections shown in C, D-G and J-L
were counterstained with DAPI.
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926Figure 5. Expression characteristics of dual promoter vectors constructed using rhodopsin kinase (RK) and interphotorecepter binding protein
(IRBP)156 promoters. pFIN-RK-GFP-IRBP156-CHER-WPRE (3.3×107 vector genomes/µl; A-E and F-J), pFIN-IRBP156-CHER-RK-GFP-
WPRE (1.5×109 vector genomes/µl; K-O and P-T), pFIN-RK-GFP-RK-CHER-WPRE (1.85×107 vector genomes/µl; U-Y and Z-DD), or
pFIN-IRBP156-CHER-IRBP156-GFP-WPRE (1.7×109 vector genomes/µl; EE-II and JJ-NN) lentivirus was injected into the developing
neural tubes of E2 chicken embryos in ovo. A minimum of four retinal whole mounts were examined for each virus. Retinal regions shown
in the figure were selected to illustrate the range of transgene expression characteristics observed in infected cells. Each region was
photographed twice using the exposure duration shown in the lower left of each panel and filters appropriate for detection of CHER or GFP.
Each row in the figure shows one selected region. The merged images (C, H, M, R, W, BB, GG, LL) were analyzed using the co-localization
module of the Zeiss AxioVision Image Suite. The results of these analyses are expressed as the percent of the transduced area in the image
(pixels) containing co-localized GFP and CHER (yellow bar) or GFP (green bar) or CHER (red bar) fluorescence alone. (D, I, N, S, X, CC,
HH, MM). The images shown in E, J, O, T, Y, DD, II, NN were extracted from the merged images (C-LL) and show only those areas of
the merged image in which GFP was co-localized with CHER. The scale bar shown in A is applicable to all images and equals 50 µm.
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927transgenes:  pFIN-RK-GFP-HS4(2×250)F-IRBP156-CHER-
WPRE  (Figure  7A-E,F-J)  and  pFIN-RK-GFP-HS4(1.2)F-
IRBP156-CHER-WPRE (Figure 7K-O,P-T). Examination of
retinas transduced with these vectors showed that insertion of
either  insulator  between  the  transgenes  did  not  markedly
increase  expression  levels  of  the  upstream  GFP  reporter
protein relative to the downstream CHER reporter protein
(compare Figure 7A to Figure 7B and Figure 7K to Figure
7L). There was some evidence that the relative percent of the
transduced cells that expressed both reporter proteins was
slightly higher in the presence of the insulators, but clearly the
expression levels of both proteins did not approach those
obtained  from  the  pFIN-IRBP156-CHER-RK-GFP-WPRE
vector. The maximum percent of the transduced area of retinas
expressing both transgenes with the non-insulated vector was
about 19% (Figure 5D), whereas the maximum percents for
retinas  transduced  with  pFIN-RK-GFP-HS4(2×250)F-
IRBP156-CHER-WPRE  or  pFIN-RK-GFP-HS4(1.2)F-
IRBP156-CHER-WPRE  were  32%  (Figure  7I)  or  36%
(Figure  7N),  respectively.  Based  on  these  analyses,  we
concluded that the slight improvement that we observed in
transgene co-expression in transduced cells, while of interest,
was not sufficient to continue to pursue further development
of these vectors (results summarized in Table 3).
Next, we focused on building a dual promoter vector that
targets rod cells and reliably expresses both of the transgenes
carried by the vector. To build this vector we used the XOPS
(1,370 bp; Figure 1) and MOPS (477 bp [18];) promoters, both
Figure  6.  Cellular  specificity  of  the
pFIN-IRBP156-CHER-RK-GFP-
WPRE  dual-promoter  vector.  pFIN-
IRBP156-CHER-RK-GFP-WPRE
(1.5×109 vector genomes/µl) lentivirus
was injected into the developing neural
tubes of E2 chicken embryos in ovo. The
retinas  of  the  injected  embryos  were
harvested  on  E19–20,  examined  as
whole mounts using native fluorescent,
and  sectioned  (10  µm).  A-C:  A
representative  section  showing  the
extent of photoreceptor infection. The
merged image indicates that nearly all
cells  are  co-expressing  the  two
fluorescent reporter proteins, CHER and
GFP.  D-F:  Close  up  of  transduced
photoreceptor layer in region containing
INL cells expressing the viral transgene
(arrow  in  D).  All  sections  were
counterstained  with  DAPI.  All  scale
bars shown equal 50 µm. Abbreviations:
ONL represents outer nuclear layer; INL
represents  inner  nuclear  layer;  IPL
represents inner plexiform layer.
TABLE 3. SUMMARY OF DUAL-PROMOTER VECTOR ACTIVITIES IN CHICKEN RETINA
  Relative percent of transduced cells expressing reporters
Vector Cells only expressing
upstream reporter
Cells only expressing
downstream reporter
Cells expressing
both reporters
RK-GFP-IRPB156-CHER 25 64 11
IRBP156-CHER-RK-GFP 12 13 75
XOPS-tdTOM-MOPS-GFP 35 33 32
MOPS-GFP-XOPS-tdTOM 24 25 51
RK-GFP-RK-CHER 13 62 25
IRBP156-CHER-IRBP156-GFP 6 53 41
RK-GFP-HS4(2x250)F-IRBP156-CHER 3 70 27
RK-GFP-HS4(1.2)F-IRBP156-CHER 25 47 28
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928of  which  exhibit  strong  specific  activity  in  rod  cells.  We
constructed  two  different  dual-promoter  reporter  vectors
using these promoters and examined their expression in vivo:
pFIN-XOPS-tdTOM-MOPS-GFP  and  pFIN-MOPS-GFP-
XOPS-tdTOM-WPRE. The fluorescent signals generated by
tdTOM  and  GFP  in  retinas  infected  with  pFIN-XOPS-
tdTOM-MOPS-GFP were easily detected, but the levels of
expression of each protein varied within transduced areas with
less than 50% of the transduced cells expressing enough of
both of these proteins to be identified as tdTOM and GFP
positive  (Figure  8A-E:  25%  co-localized,  F-J:  38%  co-
localized). Neither transgene was preferentially expressed in
transduced  cells.  In  some  areas  (Figure  8A-E),  only
expression of the upstream transgene (tdTOM) was detected
(60% of the cells in the transduced region), whereas in other
areas  (Figure  8F-J),  only  expression  of  the  downstream
transgene  (GFP)  was  detected  (52%  of  the  cells  in  the
transduced region). Reversing the positions of the XOPS and
MOPS promoter-driven transgenes in the vector altered the
expression profile of the two transgenes. In retinas infected
with  pFIN-MOPS-GFP-XOPS-tdTOM-WPRE,  the
fluorescent signal generated by the upstream reporter (GFP)
could be detected in transduced regions but the signal was
faint compared to that generated by the downstream reporter
(tdTOM; Figure 8 compare Figure 8K,P to Figure 8L,Q). Even
though the GFP signal was faint, it was detectable in many of
the transduced cells. Unlike the results obtained using pFIN-
XOPS-tdTOM-MOPS-GFP,  approximately  50%  of  the
transduced cells expressed enough of both reporter proteins
to be identified as GFP and tdTOM positive (Figure 8K-O:
55% co-localized, P-T: 47% co-localized). Taken together,
the results obtained from these two dual promoter vectors do
not  point  to  a  “most  optimal”  vector;  however,  if  co-
expression  of  both  transgenes  in  infected  cells  is  the
overarching  goal,  then  pFIN-MOPS-GFP-XOPS-tdTOM-
Figure 7. The effects of internal insulators on the expression of the RK-GFP and IRBP156-CHER transgenes carried by the pFIN-RK-GFP-
IRBP156-CHER-WPRE vector. Examination of the expression of GFP and CHER in retinas transduced with pFIN-RK-GFP-HS4(2×250)F-
IRBP156-CHER-WPRE (3.3×108 vector genomes/µl; A-J) or pFIN-RK-GFP-HS4(1.2)F-IRBP156-CHER (1.2×108 vector genomes/µl; K-
T). Each lentivirus was injected into the developing neural tubes of E2 chicken embryos in ovo. The retinal whole mounts were photographed
twice using the exposure duration shown in lower left of each panel and filters appropriate for detection of GFP or CHER. The GFP and CHER
images were merged (C, H, M, R) and analyzed using the co-localization module of the Zeiss AxioVision Image Suite. The results of these
analyses are expressed as the percent of the transduced area in the image (pixels) containing co-localized GFP and CHER (yellow bar) or GFP
(green bar) or CHER (red bar) fluorescence alone D, I, N, S. The images shown in E, J, O, T were derived from the merged images (C, H,
M, R) and show only those areas of the merged image in which GFP and CHER were co-localized. The scale bar shown in A is applicable to
all images and equals 50 µm.
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929WPRE would seem to be the vector of choice (see Table 3 for
result summary).
Finally, we built and tested one dual-promoter vector to
target Müller cells. Our analyses of the VIM, CD44 and GFAP
promoters  showed  that  the  GFAP  promoter  was  the  only
promoter  that  was  expressed  exclusively  in  Müller  cells
(Figure  2).  Although  we  found  that  the  GFAP  promoter
possessed the desired specificity, we also found that the levels
of expression of this promoter in retinas unaffected by injury
or  disease  were  not  high  enough  to  produce  detectable
amounts of reporter protein. Even though the CD44 and VIM
promoters did not exhibit the cellular specificity shown by the
GFAP promoter, we chose to pair them in building the pFIN-
CD44-CHER-VIM-GFP-WPRE vector. Our decision to pair
these  promoters  was  prompted,  in  part,  by  our  previous
observation  that  the  specificity  of  two  promoters  can  be
enhanced  when  paired  in  the  dual-promoter  configuration
[18]. Examination of retinas transduced with pFIN-CD44-
CHER-VIM-GFP-WPRE revealed a somewhat unexpected
result (Figure 9). Only the downstream reporter protein (GFP)
was detected using fluorescent microscopy (Figure 9A,C,D).
The  levels  of  the  upstream  reporter  protein  (CHER),  if
produced, were not high enough to permit direct visualization
of the native protein (Figure 9B,D). Interestingly, the activity
of the VIM promoter was more restricted so that only a few
GFP-positive  horizontal  cells  were  detected  (Figure  9E)
relative  to  the  numbers  of  these  cells  observed  in  retinas
transduced  with  pFIM-VIM-GW  (Figure  2).  Clearly,  this
dual-promoter vector did not meet our performance criteria
for generating detectable amounts of the fluorescent reporter
proteins encoded by the two transgenes carried by the vector.
DISCUSSION
Viral  vectors  are  useful  vehicles  for  delivering  genes  to
populations of cells. In many cases, it is desirable to limit
expression of these genes to specific subpopulations of cells.
Figure 8. Expression characteristics of dual promoter vectors constructed using murine opsin promoter (MOPS) and Xenopus opsin promoter
(XOPS)  promoters.  pFIN-XOPS-tdTOM-MOPS-GFP  (1.6×108  vector  genomes/µl;  A-J)  or  pFIN-MOPS-GFP-XOPS-tdTOM-WPRE
(4.4×108 vector genomes/µl; K-T) lentivirus was injected into the developing neural tubes of E2 chicken embryos in ovo. Retinal whole
mounts (one retina per horizontal row) were photographed twice using the exposure duration shown in lower left of each panel and filters
appropriate for detection of tdTOM or GFP. The merged images (C, H, M, R) were analyzed using the co-localization module of the Zeiss
AxioVision Image Suite. The relative percent area (pixels) of each image containing GFP (green bar) or tdTOM (red bar) fluorescence alone
or both GFP and tdTOM (yellow bar) is shown in panels D, I, N, S. The images shown in E, J, O, T were derived from the merged images
(C, H, M, R) and show only those areas of the merged image in which GFP was co-localized with CHER. The scale bar shown in A is
applicable to all images and equals 50 µm.
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930For many retinal diseases, photoreceptor cells are the targeted
cell subpopulation. We have now completed in vivo analyses
of seven promoters in chicken retina and have identified two
promoters  that  are  active  in  cone  cells  (GCAP292  and
IRBP1783) [18], three promoter that are active in cone and
rod cells (IRBP156, RK, NRLL; Figure 1), and two promoters
that are active in rod cells (MOPS [18] and XOPS; Figure 1).
Of these seven, GCAP292 (601 bp), IRBP156 (350 bp), and
RK (292 bp) also exhibited minor activity in cells located in
the inner nuclear layer. Since one of the goals of this study
was  to  develop  dual-promoter  lentiviral  vectors  targeting
photoreceptors, we deemed that the slight loss in cellular
specificity exhibited by these promoters would be acceptable
in view of the relatively small size of these promoters that is
advantageous when constructing lentiviral vectors.
In addition to our analyses of photoreceptor promoters,
we also examined the activities of three putative glial-specific
promoters, VIM, CD44 and GFAP, with the aim of developing
a dual-promoter lentiviral vector targeting Müller cells. These
promoters have been reported to be glial-specific in rat retina
when incorporated into lentiviral vectors pseudotyped with
vesicular  stomatitis  virus  glycoprotein  and  delivered  via
subretinal injection [25]. The results of our analyses showed
that the activities of the CD44 and VIM promoters in chicken
retina were not limited to Müller glia. CD44-driven GFP was
detected in all retinal cell types including Müller cells, and
VIM-driven GFP was detected primarily in horizontal and
Müller cells (Figure 2). The only promoter that exhibited
Müller cell-specific activity in chicken retina was the GFAP
promoter and its level of activity was positively correlated
with  the  presence  of  retinal  injury  or  disease,  an  activity
profile that matches that observed in the S334Ter+/− transgenic
rat [25]. Our observation that the CD44 and VIM promoters
are  active  in  multiple  cell  types  in  chicken  retina  was
unexpected in view of previous analyses of the activities of
these promoters in rat retina that showed that the activities of
these promoters were restricted to Müller cells [25]. While we
do not know the reason for the differences observed in the
cellular specificities of these promoters in chicken and rat
retina,  it  is  unlikely  that  they  reflect  differences  in  the
lentiviral vectors used in these studies because (1) the VIM
lentivirus was packaged using the same vector that was used
in the rat study and (2) the CD44 promoter used in our study
was removed from the pFmCD44.1GW lentivector used in the
rat study [25] and placed into our pFIN lentivector backbone
[18] which is very similar to the pFUGW lentivector backbone
[37] that was used to create pFmCD44.1GW. We propose that
the differences observed in the cellular specificities of these
promoters  reflect  differences  in  the  timing  and  routes  of
delivery of the viruses used in these studies. In the rat study,
Figure 9. Expression characteristics of a dual promoter vector constructed using cluster differentiation (CD)44 and vimentin (VIM) promoters.
pFIN-CD44-CHER-VIM-GFP-WPRE lentivirus was injected into the developing neural tubes of E2 chicken embryos in ovo. Retinal whole
mounts were photographed twice using filters appropriate for detection of GFP (A) or CHER (B) and the exposure times (ms) shown in the
lower left of the images. The GFP and CHER images were merged (C) and analyzed using the co-localization module of the Zeiss AxioVision
Image Suite. The relative percent area (pixels) of the merged image containing GFP (green bar) or CHER (red bar) fluorescence alone or both
GFP and CHER (yellow bar) is shown in panel D. Sections of the transduced retinas revealed that GFP expression was largely restricted to
Müller cells (arrow, E). A few GFP-positive horizontal cells were detected in these retinas but their numbers were reduced relative to the
numbers of these cells that were present in retinas transduced with pFM-VIM-GW (Figure 2J-N). Scale bars shown in A and E equal 50 µm.
Molecular Vision 2010; 16:916-934 <http://www.molvis.org/molvis/v16/a102> © 2010 Molecular Vision
931the viruses were injected into the subretinal space at postnatal
days 1 and 21; whereas in our study, the viruses were injected
into the neural tubes of E2 chicken embryos when the optic
vesicles  have  formed  and  the  neural  tube  is  closing.  The
biggest difference between these approaches is the types of
cells that come into contact with the injected lentiviruses. The
subretinal approach, while maximizing exposure of the retinal
pigment epithelium, photoreceptors and Müller cells to virus,
limits  exposure  of  the  cells  of  the  inner  retina  to  virus.
Delivery of virus to the developing embryo, on the other hand,
exposes retinal progenitor cells to virus whose daughter cells,
each  of  which  carry  the  integrated  viral  transgene,
differentiate to form the entire neural retina. The observations
that  AAV2-CD44-GFP  was  active  in  a  subset  of  retinal
ganglion cells [25] and that GFP was present in amacrine and
ganglion  cells  in  CD44-GFP  transgenic  mice  [38]  are
consistent with our observation that the CD44 promoter is
capable of activity in a broader array of cell types than has
been previously suggested by studies of mouse retina showing
that  the  CD44  protein  is  restricted  to  Müller  cells  [39].
Together, these observations serve to highlight the importance
of considering developmental stage, viral type, and delivery
route when characterizing the expression characteristics of
promoters in vivo.
Much of our effort in this study was directed toward
developing  dual-promoter  vectors  that  specifically  target
cones and rods, rods alone, and Müller cells. For the vector
targeting  cones  and  rods,  the  performance  of  the  dual
promoter vector carrying the IRBP156 and RK promoters
with  IRBP156  in  the  upstream  position  was  the  most
consistent of those tested, exhibiting high levels (~70%) of
expression of both of the proteins carried by the vector in
transduced cone and rod cells. Reversal of the order of the
appearance of the two promoters in the dual promoter vector
dramatically reduced the expression levels of the upstream
gene  driven  by  RK,  a  phenomenon  termed  promoter
suppression [40]. Unequal expression of one of the cistrons
carried by bicistronic constructs is often problematic when
developing lentiviral vectors carrying multiple, heterologous
promoters  [40,41].  We  do  not  know  the  mechanism
underlying the interference exhibited by this vector, but since
it is dependent on promoter order and the levels of expression
of  the  upstream  gene  are  compromised,  it  may  be  that
transcription  of  the  downstream  gene  induces  structural
changes in the bicistronic transgene that prevents efficient
transcription from the upstream promoter. To see if we could
ameliorate suppression of expression of the upstream cistron,
we  inserted  an  HS4  insulator  between  the  RK-GFP  and
IRBP156-CHER  cistrons.  This  approach  has  been
successfully used by others to overcome positional effects that
adversely impact the expression of individual cistrons carried
by  multi-gene  lentiviral  vectors  [36].  We  found  that  the
relative level of expression of the RK-GFP cistron to that of
the IRBP156-CHER cistron following insertion of either the
2×250  or  the  1.2-kb  HS4  insulator  between  the  cistrons
improved slightly but did not approach that obtained from the
vector  carrying  the  cistrons  in  the  reverse  order  (pFIN-
IRBP156-CHER-RK-GFP-WPRE). Further improvements in
the performance of this vector could potentially be achieved
by cloning the cistrons into the vector backbone in antisense
orientation and adding polyadenylation signals to each cistron
[16] or by inserting a second WPRE element between the two
cistrons [42].
In addition to the dual promoter photoreceptor-specific
vectors that we constructed, we also constructed and tested
the performance of a dual promoter vector that was designed
to target Müller cells. In designing this vector, we paired the
CD44  and  VIM  promoters  to  create  pFIN-CD44-CHER-
VIM-GFP-WPRE.  Both  of  these  promoters  are  active  in
Müller  cells  but  are  also  active  in  non-glial  cells.  We
hypothesized, based on our previous observation that pairing
promoters can increase the specificity of each promoter [18],
that placing these two promoters in a tandem cis arrangement
would enhance the glial specificity of the other. The result
obtained  using  this  vector  was  somewhat  unexpected.
Expression of CHER from the upstream CD44-CHER cistron
was  undetectable,  while  expression  of  GFP  from  the
downstream  VIM-GFP  cistron  was  detected  primarily  in
Müller cells with little GFP detected in horizontal cells, an
observation  that  suggests  that  pairing  VIM  with  CD44
increased the specificity of the VIM promoter with regard to
glial cells. Our goal was to obtain a vector that efficiently
drives expression of two proteins in transduced Müller cells.
Given the results obtained with this vector, we may be able to
accomplish this goal by either developing a dual promoter
vector in which we pair the GFAP promoter with the VIM
promoter or by developing a multi-cistron transgene driven
by  either  the  GFAP  or  VIM  promoter  that  contains  self-
cleaving 2A-like peptides that promote generation of multiple
proteins from a single transcript [25].
Our goal for this study was to develop dual-promoter
lentiviral vectors that exhibited photoreceptor or Müller cell-
specific expression that consistently produced two proteins in
the  targeted  cells.  Using  combinations  of  photoreceptor
promoters we were able to develop vectors that are expressed
in specific populations of retinal cells, namely vectors that
target cone and rod cells (pFIN-IRBP156-CHER-RK-GFP-
WPRE)  or  that  target  rod  cells  only  (pFIN-MOPS-GFP-
XOPS-tdTOM-WPRE). Analyses of the expression of the two
proteins encoded by these vectors using direct fluorescence
revealed that detection of one protein was predictive of the
presence of the second protein in greater than 50% of the
infected  cells.  For  the  pFIN-IRBP156-CHER-RK-GFP-
WPRE vector this percentage was closer to 80%, a value that
would likely have been higher if antibodies had been used to
aid  in  the  visualization  of  the  fluorescent  proteins.  These
vectors should be useful in studies of retina when co-delivery
of a reporter protein with an experimental protein is desired
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932or when expression of two exogenous proteins in targeted cells
is required.
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